article thumbnail

New insight into BRCA2 gene mutations and cancer risk

Drug Target Review

Researchers from the University of California, Davis delved deeper into the mechanisms of DNA repair and cancer development by studying the BRCA2 gene at the molecular level. The study’s findings provide new insights into the origins of cancer and DNA repair mechanisms.

DNA 52
article thumbnail

Determining Disease Risks Based on Genetic Ancestry Can Counter Health Care Disparities, But Doesn’t Go Far Enough

PLOS: DNA Science

Tools to Track Disease: Biobanks to AI The new investigation looks at points in a human genome that can be any of the four types of DNA building blocks – A, C, T, or G. DNA samples used in genetic research came mostly from deCODE Genetics (begun in 1996, on the Icelandic population) and the UK Biobank (begun in 2006).

Disease 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Topical Gene Therapy FDA-Approved for Severe Skin Disease, Dystrophic Epidermolysis Bullosa

PLOS: DNA Science

DEB has been a candidate for a gene therapy since 2002. This DNA Science post from 2018 traces the history of the efforts. ” The post Topical Gene Therapy FDA-Approved for Severe Skin Disease, Dystrophic Epidermolysis Bullosa appeared first on DNA Science. RDEB is inherited from two carrier parents.

article thumbnail

OBI Pharma Announces Presentations at ESMO Asia 2020 Virtual Annual Meeting for OBI-833, a Novel Anti-Globo H Targeted Therapeutic Cancer Vaccine

The Pharma Data

is a Taiwan biopharmaceutical company that was established in 2002. The company’s novel first-in-class AKR1C3 targeted therapy is OBI-3424 (small-molecule prodrug) that selectively releases a potent DNA alkylating agent in the presence of the aldo-keto reductase 1C3 (AKR1C3) enzyme. About OBI Pharma. OBI Pharma, Inc.,

Vaccine 52
article thumbnail

The evolution of cell therapy to address unmet medical needs

Drug Target Review

The other powerful benefit is that our cell lines can become any of the cell types of the human body – these cells have within their DNA the capability to become any of the more than 200 human cell types which you might want to manufacture. This provides some regulatory advantages, and of course, significant cost advantages.

article thumbnail

What Took So Long: How Tech Has Finally Caught Up With Transcription Factors

LifeSciVC

These hair clip-like molecules clamp onto DNA, thereby turning many genes on and off. Darnell’s 2002 paper Transcription Factors as Targets for Cancer Therapy , in which he wrote: “A limited list of transcription factors are overactive in most human cancer cells, which makes them targets for the development of anticancer drugs.

article thumbnail

TACACICLIB, AUR-102, AURIGENE

New Drug Approvals

CDK7 also plays a role in transcription and possibly in DNA repair. The trimeric Cak complex CDK7/CyclinH/MATl is also a component of TFIIH, the general transcription/DNA repair factor IIH (Morgan, DO., 8, 3527-3538, 2002). 13, 261-91, 1997). Konig et al., Cancer Res.